(Q34218309)

31 July 2017

1 reference

title

Neurogenic inflammation in the context of migraine (English)

1 reference

31 July 2017

0 references

1 reference

neurogenic inflammation

1 reference

D J Williamson

1

1 reference

PubMed ID

11301492

31 July 2017

R J Hargreaves

series ordinal

2

1 reference

31 July 2017

1 May 2001

1 reference

Microscopy Research and Technique

31 July 2017

1 reference

31 July 2017

53

1 reference

31 July 2017

3

1 reference

31 July 2017

167-178

1 reference

Migraine with aura shows gadolinium enhancement which is reversed following prophylactic treatment.

31 July 2017

1 reference

Modulation of neurogenic inflammation: novel approaches to inflammatory disease

21 January 2018

1 reference

The pre- and postjunctional activity of CP-122,288, a conformationally restricted analogue of sumatriptan

21 January 2018

1 reference

Morphine and somatostatin analogue reduce c-fos expression in trigeminal subnucleus caudalis produced by corneal stimulation in the rat.

21 January 2018

1 reference

Role of endothelin in mediating neurogenic plasma extravasation in rat dura mater.

21 January 2018

1 reference

The antimigraine drug, sumatriptan (GR43175), selectively blocks neurogenic plasma extravasation from blood vessels in dura mater

21 January 2018

1 reference

Lack of a role for substance P in the control of dural arterial flow

21 January 2018

1 reference

Familial hemiplegic migraine with crossed cerebellar diaschisis and unilateral meningeal enhancement

21 January 2018

1 reference

Attenuation by valproate of c-fos immunoreactivity in trigeminal nucleus caudalis induced by intracisternal capsaicin

21 January 2018

1 reference

Effects of PNU-109,291, a selective 5-HT1D receptor agonist, on electrically induced dural plasma extravasation and capsaicin-evoked c-fos immunoreactivity within trigeminal nucleus caudalis.

21 January 2018

1 reference

Antiemetic activity of the NK1 receptor antagonist GR205171 in the treatment of established postoperative nausea and vomiting after major gynaecological surgery.

21 January 2018

1 reference

Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist

21 January 2018

1 reference

Calcitonin gene-related peptide and cerebral blood vessels: distribution and vasomotor effects

21 January 2018

1 reference

Trigeminal ganglion stimulation increases facial skin blood flow in the rat: a major role for calcitonin gene-related peptide

21 January 2018

1 reference

The modulation of the increase in rat facial skin blood flow observed after trigeminal ganglion stimulation

21 January 2018

1 reference

Transnasal butorphanol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in acute pain management

21 January 2018

1 reference

The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats.

21 January 2018

1 reference

Vasoactive peptide release in the extracerebral circulation of humans during migraine headache

21 January 2018

1 reference

Ineffectiveness of neurokinin-1 antagonist in acute migraine: a crossover study

21 January 2018

1 reference

Neurogenic vasodilatation and plasma leakage in the skin

21 January 2018

1 reference

Mode of action of the anti-migraine drug sumatriptan

21 January 2018

1 reference

Increase of meningeal blood flow after electrical stimulation of rat dura mater encephali: mediation by calcitonin gene-related peptide

21 January 2018

1 reference

Conformationally restricted sumatriptan analogues, CP-122,288 and CP-122,638 exhibit enhanced potency against neurogenic inflammation in dura mater

21 January 2018

1 reference

Peripheral GABAA receptor-mediated effects of sodium valproate on dural plasma protein extravasation to substance P and trigeminal stimulation

21 January 2018

1 reference

Coexistence of calcitonin gene-related peptide and substance P-like peptide in single cells of the trigeminal ganglion of the rat: immunohistochemical analysis.

21 January 2018

1 reference

Sumatriptan relieves migrainelike headaches associated with carbon monoxide exposure

21 January 2018

1 reference

Differential distribution of 5HT1D- and 5HT1B-immunoreactivity within the human trigemino-cerebrovascular system: implications for the discovery of new antimigraine drugs.

21 January 2018

1 reference

Retinal plasma extravasation in animals but not in humans: implications for the pathophysiology of migraine.

21 January 2018

1 reference

Effects of the 5-HT1 receptor agonists, sumatriptan and CP 93,129, on dural arterial flow in the rat.

21 January 2018

1 reference

The neurobiology of vascular head pain

21 January 2018

1 reference

Neurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraine

21 January 2018

1 reference

Regulation of substance P release mediated via prejunctional histamine H3 receptors

21 January 2018

1 reference

The pharmacology of current anti-migraine drugs

21 January 2018

1 reference

Characterization of LY344864 as a pharmacological tool to study 5-HT1F receptors: binding affinities, brain penetration and activity in the neurogenic dural inflammation model of migraine

21 January 2018

1 reference

Characterization of ligand binding properties of the 5-HT1D receptors cloned from chimpanzee, gorilla and rhesus monkey in comparison with those from the human and guinea pig receptors

21 January 2018

1 reference

Differential pharmacology between the guinea-pig and the gorilla 5-HT1D receptor as probed with isochromans (5-HT1D-selective ligands)

21 January 2018

1 reference

Selective 5-HT1D alpha serotonin receptor gene expression in trigeminal ganglia: implications for antimigraine drug development

21 January 2018

1 reference

The non-peptide neurokinin1 receptor antagonist, RP 67580, blocks neurogenic plasma extravasation in the dura mater of rats

21 January 2018

1 reference

Differential effects of 5-HT1B/1D receptor agonists on neurogenic dural plasma extravasation and vasodilation in anaesthetized rats.

21 January 2018

1 reference

Possible antimigraine mechanisms of action of the 5HT1F receptor agonist LY334370.

21 January 2018

1 reference

Origins and pathways of cerebrovascular nerves storing substance P and calcitonin gene-related peptide in rat.

21 January 2018

1 reference

Neuronal pathways to the rat middle meningeal artery revealed by retrograde tracing and immunocytochemistry.

21 January 2018

1 reference

Intravital microscope studies on the effects of neurokinin agonists and calcitonin gene-related peptide on dural vessel diameter in the anaesthetized rat.

21 January 2018

1 reference

Sumatriptan inhibits neurogenic vasodilation of dural blood vessels in the anaesthetized rat--intravital microscope studies

21 January 2018

1 reference

The novel anti-migraine agent rizatriptan inhibits neurogenic dural vasodilation and extravasation.

21 January 2018

1 reference

A double-blind study of subcutaneous dihydroergotamine vs subcutaneous sumatriptan in the treatment of acute migraine

21 January 2018

1 reference

Blood flow velocities in the vertebrobasilar system during migraine attacks--a transcranial Doppler study

21 January 2018

1 reference

Migraine pain associated with middle cerebral artery dilatation: reversal by sumatriptan

21 January 2018

1 reference

Distribution and effects of neuropeptide Y, vasoactive intestinal peptide, substance P, and calcitonin gene-related peptide in human middle meningeal arteries: Comparison with cerebral and temporal arteries

21 January 2018

1 reference

Focal hyperemia followed by spreading oligemia and impaired activation of rcbf in classic migraine

21 January 2018

1 reference

Cerebral Blood Flow Velocities are Reduced During Attacks of Unilateral Migraine Without Aura

21 January 2018

1 reference

Evidence for the presence of 5-HT1B receptor messenger RNA in neurons of the rat trigeminal ganglia

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JEMT.1081

1 reference

31 July 2017

1 reference

PubMed ID

11301492